ww glp-1 The @WeightWatchers program provides personalized support for GLP-1 users, making weight wellness a journey of success and empowerment. Learn more of the GLP-1 program by visiting Weight Watchers Releases GLP-1 Results

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...

Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection

The global burden of chronic disorders such as Parkinsons disease (PD) has rapidly increased over recent decades

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant